MediciNova Inc (NASDAQ:MNOV)

2.15
Delayed Data
As of 3:56pm ET
 -0.01 / -0.46%
Today’s Change
2.08
Today|||52-Week Range
4.65
-19.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$105.9M

Company Description

MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

Contact Information

MediciNova, Inc.
4275 Executive Square
La Jolla California 92037
P:(858) 373-1500
Investor Relations:

Employees

Shareholders

Mutual fund holders5.46%
Individual stakeholders22.37%
Other institutional17.73%

Top Executives

Yuichi IwakiPresident, Chief Executive Officer & Director
Jason KrugerChief Financial Officer
Kazuko MatsudaDirector & Chief Medical Officer
Geoffrey G. O'BrienVice President & Executive Officer
David H. CreanChief Business Officer